- Home
- ETY vs CPRX Comparison
ETY vs CPRX Comparison
Compare ETY & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETY
- CPRX
- Stock Information
- Founded
- ETY 2006
- CPRX 2002
- Country
- ETY United States
- CPRX United States
- Employees
- ETY N/A
- CPRX N/A
- Industry
- ETY Finance Companies
- CPRX Biotechnology: Pharmaceutical Preparations
- Sector
- ETY Finance
- CPRX Health Care
- Exchange
- ETY Nasdaq
- CPRX Nasdaq
- Market Cap
- ETY 2.4B
- CPRX 2.6B
- IPO Year
- ETY N/A
- CPRX 2006
- Fundamental
- Price
- ETY $15.89
- CPRX $20.07
- Analyst Decision
- ETY
- CPRX Strong Buy
- Analyst Count
- ETY 0
- CPRX 5
- Target Price
- ETY N/A
- CPRX $33.20
- AVG Volume (30 Days)
- ETY 247.3K
- CPRX 1.4M
- Earning Date
- ETY 01-01-0001
- CPRX 08-06-2025
- Dividend Yield
- ETY 7.21%
- CPRX N/A
- EPS Growth
- ETY N/A
- CPRX 183.96
- EPS
- ETY N/A
- CPRX 1.65
- Revenue
- ETY N/A
- CPRX $558,499,000.00
- Revenue This Year
- ETY N/A
- CPRX $16.37
- Revenue Next Year
- ETY N/A
- CPRX $8.80
- P/E Ratio
- ETY N/A
- CPRX $12.18
- Revenue Growth
- ETY N/A
- CPRX 28.55
- 52 Week Low
- ETY $10.59
- CPRX $19.00
- 52 Week High
- ETY $13.46
- CPRX $26.58
- Technical
- Relative Strength Index (RSI)
- ETY 61.39
- CPRX 40.47
- Support Level
- ETY $15.72
- CPRX $19.36
- Resistance Level
- ETY $15.97
- CPRX $20.51
- Average True Range (ATR)
- ETY 0.19
- CPRX 0.74
- MACD
- ETY 0.01
- CPRX -0.06
- Stochastic Oscillator
- ETY 90.80
- CPRX 27.22
About ETY Eaton Vance Tax-Managed Diversified Equity Income Fund of Beneficial Interest
Eaton Vance Tax-mgd Dvsf Eq Inc Fd is a diversified, closed-end management investment company. Its primary investment objective is to provide current income and gains. The secondary objective of the fund is capital appreciation. Its portfolio of investments consists of capital markets, banks, internet and direct marketing retail, biotechnology, media, oil, gas, and consumable fuels, and other sectors.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).